Riskpilot← Back to searchSign inGet full accessCurativus AB
ABActiveOrg 5569478646Västmannagatan 66General medical practice activities · NACE 8621Est. 20130 employees
Revenue 2024
SEK 1M
+13% vs 2023
EBITDA margin
87.6%
+7% vs 2023
Equity ratio
70.0%
Financial strength
Net profit 2024
SEK 706K
+6% vs 2023
| Revenue | SEK 1M | +13% |
| EBITDA | SEK 903K | +7% |
| Net profit | SEK 706K | +6% |
| Total assets | SEK 2,6M | +26% |
| Equity | SEK 1,8M | +13% |
| Employees | 0 | — |
Legal name
Curativus AB
Org number
5569478646
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
6 november 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkarverksamhet, medicinsk konsultverksamhet samt handel med och förvaltning av fastigheter och värdepapper jämte annan därmed förenlig verksamhet.
Address
Västmannagatan 66
Email
perbystroem@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 167 | 450 | 882 | 911 | 1 031 |
| Staff expenses | — | — | −13 | −48 | −52 |
| EBITDA | 164 | 441 | 864 | 845 | 903 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 164 | 441 | 864 | 845 | 903 |
| Net financials | — | — | −1 | −2 | −10 |
| Profit before tax | 164 | 441 | 863 | 843 | 893 |
| Tax | −30 | −91 | −178 | −174 | −186 |
| Net profit | 134 | 350 | 685 | 669 | 706 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 261 | 778 | 1 664 | 2 098 | 2 639 |
| Equity | 177 | 527 | 1 092 | 1 641 | 1 847 |
| Long-term debt | 10 | 14 | 0 | — | — |
| Short-term debt | 74 | 237 | 572 | 457 | 792 |
| Total debt | 84 | 251 | 572 | 457 | 792 |
EBITDA margin
87.6%
This company
15.8%
Market median
+454% vs market
20202024
Equity ratio
70.0%
This company
38.2%
Market median
+83% vs market
20202024
Return on equity
38.2%
This company
18.4%
Market median
+108% vs market
20202024
Net profit margin
68.5%
This company
8.1%
Market median
+746% vs market
20202024
Asset turnover
0.39×
This company
1.12×
Market median
-65% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Curativus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Johannes Byström | Board of Directors | 0 companies |
| Hans Lennart Brynolf Börjesson | Deputy Board Member | 0 companies |